Updated Date: Mon, 11 May 2020 00:00:00 EDT
Category: Uncategorized
More threat to Gilead’s HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada aliu Mon, 05/18/2020 – […]
FiercePharmaPolitics—COVID-19 brings divisions on hydroxychloroquine, reopening esagonowsky Mon, 05/18/2020 – 10:15
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report kblankenship Mon, 05/18/2020 – 10:25
Deciphera fills in where Blueprint falls short with early FDA nod in rare stomach cancer aliu Mon, 05/18/2020 […]
For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM) has […]
Researchers at the University of Eastern Finland have developed a new and promising drug compound for the treatment […]
“Healthcare staff should work together with patients and carers to educate the next generation of doctors, we’re on […]
The move comes as Oxford Uni and AZ sign a global licensing deal for their vaccine candidate